Special Educational Needs: support in England
An overview of the current system of support for children and young people with special educational needs, and pressure on the system. Updated with new 2024-25 SEND incidence and EHC plan data

This debate pack has been prepared ahead of the debate on decommissioning of in vitro fertilisation and other NHS fertility services to be held in Westminster Hall on Thursday 19th January. The debate is being sponsored by Steve McCabe, Edward Vaizey and Tom Brake.
Decommissioning of IVF and other NHS fertility services (222 KB , PDF)
Difficulty conceiving is a problem that affects around one in seven couples in the UK. According to NHS Choices, 84% of couples will conceive naturally within a year if they have regular unprotected sex, while 92% will conceive within two years.
The National Institute for Clinical Excellence (NICE) recommends that couples who have been unsuccessful in conceiving after two years should be offered three full cycles of in vitro fertilisation (IVF) for women under 40, and one cycle for women between 40 and 42. However, these are guidelines, and Clinical Commissioning Groups (CCGs) are not legally required to implement them. There is substantial variation between CCGs in England in terms of what fertility treatments are routinely funded.
According to Fertility Fairness, 35 CCGs offer three cycles of IVF to women under 40, but just four CCGs out of 209) offer funding for fertility treatment which is fully in line with the NICE guidelines, all of which are in Greater Manchester. Four CCGs currently do not routinely fund any fertility treatment: Mid Essex, North East Essex, Basildon & Brentwood and South Norfolk. A number of other CCGs are currently consulting on reducing or decommissioning existing services.
There is variation between the devolved administrations regarding funding for IVF, but there is no variation within Scotland, Wales or Northern Ireland.
Decommissioning of IVF and other NHS fertility services (222 KB , PDF)
An overview of the current system of support for children and young people with special educational needs, and pressure on the system. Updated with new 2024-25 SEND incidence and EHC plan data
This briefing focuses on two disease-modifying dementia drugs that are currently being appraised by the National Institute for Health and Care Excellence (NICE): lecanemab and donanemab
A debate on children's health is scheduled to take place in the House of Commons Chamber on Thursday 10 July 2025. The subject for the debate was determined by the Backbench Business Committee, and the debate will be led by Dr Simon Opher MP.